Form 4: Emergent BioSolutions SVP Sells Shares for Tax Obligations

Emergent BioSolutions' SVP, R&D, CMO, Simon C. Lowry, disposed of 3,543 shares of common stock to cover tax liabilities from restricted stock unit vesting.

Summary

• Simon C. Lowry, SVP, R&D, CMO of Emergent BioSolutions Inc. (EBS), disposed of 3,543 shares of common stock.
• The transaction occurred on December 15, 2025, with a price of $11.41 per share.
• These shares were withheld to pay taxes associated with the vesting and settlement of restricted stock units.
• Following this transaction, Mr. Lowry beneficially owns 88,439 shares of common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax purposes related to equity compensation, which is a neutral event. It reflects the vesting of RSUs (positive for the executive) but also a reduction in direct share ownership.

Positives

• The transaction indicates the vesting and settlement of restricted stock units, which is a positive event for the executive as it represents compensation becoming liquid.
• The transaction was pre-planned under a Rule 10b5-1(c) plan, indicating a structured approach to managing equity compensation and tax obligations.

Negatives

• The disposal of shares, even for tax purposes, reduces the executive's direct ownership stake in the company.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

This Form 4 filing details a routine insider transaction related to equity compensation and tax obligations, which is common across all industries for executives receiving restricted stock units. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• This is a standard insider transaction for tax withholding upon RSU vesting, a common practice for executive compensation across publicly traded companies. No specific comparable companies, projects, or results are relevant for this type of filing.

Related Party Transactions

• The transaction involves an officer of the company, which is a related party transaction, specifically the disposal of shares to cover tax obligations arising from equity compensation.

Stakeholder Impact

• Shareholders: A minor reduction in an executive's direct ownership, but generally a neutral event as it's for tax purposes.
• Employees: Reflects standard equity compensation practices for executives.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where an executive sold shares to cover tax obligations arising from restricted stock unit vesting. Such transactions are common and generally do not indicate a change in the company's fundamental outlook or the executive's confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Emergent BioSolutions, EBS, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Simon C. Lowry, Officer Transaction, Equity Compensation